North Wales, PA, United States of America

Karl M Gelotte

This inventor holds 4 USPTO granted patents. Top assignees: Merck + Co., Inc., Aventis Pharmaceuticals Products Inc.. Active years: 1998-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl M Gelotte. Retrieved from https://idiyas.com/inventor/karl-m-gelotte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998-2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Karl M Gelotte

Introduction

Karl M Gelotte is a notable inventor based in North Wales, PA (US). He has made significant contributions to the field of pharmaceuticals and elastomer technology. With a total of 4 patents, Gelotte's work has had a meaningful impact on the development of medical devices and formulations.

Latest Patents

One of Gelotte's latest patents is an elastomer treatment process designed to decrease peroxide levels. This novel process treats crosslinked ethylene-propylene diene monomer (EPDM) elastomer material, which is crucial for the seats and neck gaskets of metering valves used in metered-dose inhalers (MDI). The treatment involves exposing EPDM components to a solution of 2-mercaptoethanol, a chemical reducing agent that effectively reduces residual peroxide levels. This innovation ensures improved compatibility with pharmaceutical formulations while retaining the favorable physical properties of the elastomer.

Another significant patent involves compositions for inhibiting platelet aggregation. This pharmaceutical composition is intended for intravenous administration and includes a pharmaceutically effective amount of 2-S-(n-Butylsulfonylamino)-3-[4-(4-(piperidin-4-yl)butyloxy)phenyl]propionic acid, along with a citrate buffer and a tonicity adjusting agent. This formulation is designed to be isotonic with the biological system of the patient, enhancing its effectiveness.

Career Highlights

Throughout his career, Gelotte has worked with prominent companies such as Merck & Co., Inc. and Aventis Pharmaceuticals Products Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and elastomer applications.

Collaborations

Gelotte has collaborated with professionals in the field, including his coworker Joseph D'Silva. These partnerships have facilitated the development of his innovative patents and have enhanced the impact of his work in the industry.

Conclusion

Karl M Gelotte's contributions to the fields of elastomer technology and pharmaceuticals are noteworthy. His innovative patents reflect his commitment to improving medical devices and formulations, making a significant difference in patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…